No (N=57) |
Yes (N=12) |
P-value | |
---|---|---|---|
Age (years) | |||
Mean (SD) | 56.3 (9.39) | 57.3 (13.5) | 0.279 |
Median [Min, Max] | 57.0 [33.0, 82.0] | 58.0 [24.0, 79.0] | |
Operation_history | |||
Direct_surgery | 42 (73.7%) | 3 (25.0%) | 0.00392 |
Surgery_after_neoadjuvant | 15 (26.3%) | 9 (75.0%) | |
Type | |||
HGSC | 57 (100%) | 12 (100%) | <0.001 |
Clinical_stage | |||
II | 3 (5.3%) | 0 (0%) | 0.0655 |
III | 32 (56.1%) | 3 (25.0%) | |
IV | 22 (38.6%) | 9 (75.0%) | |
TMB_group | |||
High | 1 (1.8%) | 1 (8.3%) | 0.782 |
Low | 55 (96.5%) | 11 (91.7%) | |
Missing | 1 (1.8%) | 0 (0%) | |
Planting_metastasis | |||
No | 3 (5.3%) | 1 (8.3%) | 1 |
Yes | 54 (94.7%) | 11 (91.7%) | |
Lymph.node_metastasis | |||
No | 23 (40.4%) | 4 (33.3%) | 0.899 |
Yes | 34 (59.6%) | 8 (66.7%) | |
Type_group | |||
HGSC | 57 (100%) | 12 (100%) | <0.001 |